Beijing Konruns Pharmaceutical Co., Ltd.

40
Sell
  • Market Cap: Mid Cap
  • Industry: Retailing
  • ISIN: CNE1000036K3
CNY
39.22
3.57 (10.01%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Million
Consolidated - Profit And Loss Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Operating Income
908.00
818.00
914.00
860.00
801.00
796.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
908.00
818.00
914.00
860.00
801.00
796.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Raw Materials Consumed
0.00
0.00
0.00
0.00
0.00
0.00
Power & Fuel Cost
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
254.00
0.00
0.00
0.00
0.00
86.00
Operating Expenses
7.00
6.00
2.00
0.00
1.00
0.00
General and Administration Expenses
564.00
545.00
575.00
512.00
467.00
524.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
726.00
701.00
786.00
740.00
686.00
687.00
Operating Profit (PBDIT) excl Other Income
182.00
117.00
127.00
119.00
114.00
109.00
Other Income
26.00
34.00
38.00
42.00
37.00
97.00
Operating Profit (PBDIT)
242.00
188.00
210.00
200.00
187.00
237.00
Interest
7.00
6.00
2.00
0.00
1.00
0.00
Profit before Depriciation and Tax
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
36.00
36.00
43.00
39.00
36.00
30.00
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
191.00
39.00
131.00
149.00
191.00
208.00
Provision for Tax
20.00
17.00
-64.00
16.00
21.00
24.00
Profit After Tax
165.00
42.00
150.00
101.00
147.00
183.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
0.00
0.00
0.00
0.00
0.00
0.00
Profit Available for appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend (%)
Earnings Per Share
1.04
0.27
0.96
0.65
0.94
1.15
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2025 is 11.00% vs -10.44% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is 55.43% vs -8.00% in Dec 2024

stock-summary

Interest

YoY Growth in year ended Dec 2025 is 22.03% vs 120.79% in Dec 2024

stock-summary

Profit After Tax

YoY Growth in year ended Dec 2025 is 293.13% vs -71.94% in Dec 2024

Compare Profit and Loss Results of Beijing Konruns Pharmaceutical Co., Ltd.
Markets Mojo
Figures in Million
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
No of Months
12
12
Operating Income
908.00
0
908.00
0%
Less :Inter divisional transfers
0.00
0
0.00
0%
Less: Excise
0.00
0
0.00
0%
Net Sales
908.00
0
908.00
0%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0
0.00
0%
Raw Materials Consumed
0.00
0
0.00
0%
Power & Fuel Cost
0.00
0
0.00
0%
Employee Cost
254.00
0
254.00
0%
Operating Expenses
7.00
0
7.00
0%
General and Administration Expenses
564.00
0
564.00
0%
Selling and Distribution Expenses
0.00
0
0.00
0%
Cost of Software developments
0.00
0
0.00
0%
Miscellaneous Expenses
0.00
0
0.00
0%
Expenses Capitalised
0.00
0
0.00
0%
Total Expenditure
726.00
0
726.00
0%
Operating Profit (PBDIT) excl Other Income
182.00
0.00
182.00
0%
Other Income
26.00
0
26.00
0%
Operating Profit (PBDIT)
242.00
0
242.00
0%
Interest
7.00
0
7.00
0%
Profit before Depriciation and Tax
0.00
0
0.00
0%
Depreciation
36.00
0
36.00
0%
Profit Before Taxation & Exceptional Items
0.00
0
0.00
0%
Exceptional Income / Expenses
0.00
0
0.00
0%
Profit Before Tax
191.00
0
191.00
0%
Provision for Tax
20.00
0
20.00
0%
Profit After Tax
165.00
0
165.00
0%
Extraordinary Items
0.00
0
0.00
0%
Adj to Profit After Tax
0.00
0
0.00
0%
Profit Balance B/F
0.00
0
0.00
0%
Profit Available for appropriations
0.00
0
0.00
0%
Appropriations
0.00
0
0.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
1.04
0
1.04
0%
Profit And Loss - Net Sales
Net Sales 908.67 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 11.00% vs -10.44% in Dec 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 182.49 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 55.43% vs -8.00% in Dec 2024

Profit And Loss - Interest
Interest 7.58 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 22.03% vs 120.79% in Dec 2024

Profit And Loss - Profit After Tax
Profit After Tax 165.97 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 293.13% vs -71.94% in Dec 2024